Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS · Delayed Price · Currency is USD
6.25
0.00 (0.00%)
Aug 26, 2025, 8:00 PM EDT
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of $556.43 million as of August 28, 2025. Its market cap has decreased by -41.83% in one year.
Market Cap
556.43M
Enterprise Value
772.22M
Revenue
216.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.25
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 343.19M to 556.43M, an increase of 62.13%. That is a compound annual growth rate of 2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 556.43M | -7.18% |
| Dec 30, 2024 | 599.46M | -33.52% |
| Dec 29, 2023 | 901.69M | -32.11% |
| Dec 30, 2022 | 1.33B | -1.47% |
| Dec 30, 2021 | 1.35B | -4.00% |
| Dec 30, 2020 | 1.40B | -8.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| CytoDyn | 396.18M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 359.30M |